{
  "question": "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) protein degradation and loss-of-function of the wild-type allele\nB) change of protein conformation and gain-of-function phenotype\nC) loss of protein dimerization and wild-type phenotype\nD) protein aggregation and loss-of-function phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>",
  "response_list": [
    "### Understanding the Mutation's Impact\n\nThis question examines the molecular consequences of different types of genetic mutations on a protein that must form a dimer to function.\n\n*   **Wild-Type Function:** The normal transcription factor subunit is activated, forms a dimer with another identical subunit, enters the nucleus, and activates gene transcription.\n*   **Recessive Loss-of-Function (Mutation X):** This mutation in the transactivation domain results in a non-functional protein. However, in a heterozygous individual (one mutant, one normal allele), the normal proteins can still form functional dimers with each other. Since this is sufficient for normal cell function, the mutation is recessive.\n*   **Dominant-Negative (Mutation Y):** This mutation in the dimerization domain is described as dominant-negative. This means the protein produced from the mutated allele interferes with the function of the protein from the normal, wild-type allele. For proteins that function as dimers, a common dominant-negative mechanism occurs when the mutant subunit can still bind to a wild-type subunit, forming a non-functional or \"poison\" dimer. This effectively removes the wild-type protein from the functional pool, leading to a loss-of-function phenotype even with a normal allele present.\n\n### Analyzing the Options\n\nGiven that mutation Y is a dominant-negative mutation in the dimerization domain of a protein that must dimerize to work, we can evaluate the likely molecular outcomes:\n\n*   **A) protein degradation and loss-of-function of the wild-type allele:** This is a plausible mechanism for a dominant-negative effect. The mutant protein could bind to the wild-type protein, creating an unstable or misfolded heterodimer that is then targeted for degradation by the cell's quality control machinery. This would lead to the depletion of the wild-type protein and a loss of its function.\n*   **B) change of protein conformation and gain-of-function phenotype:** This is incorrect. A dominant-negative mutation causes a loss-of-function phenotype, not a gain-of-function.\n*   **C) loss of protein dimerization and wild-type phenotype:** This describes a classic recessive mutation, not a dominant-negative one. If the mutation completely prevented dimerization, the mutant proteins would be unable to interfere with the wild-type proteins. The wild-type proteins could still form functional dimers, likely resulting in a normal (wild-type) phenotype, similar to the situation with mutation X.\n*   **D) protein aggregation and loss-of-function phenotype:** This is another plausible mechanism. A missense mutation in the dimerization domain could cause the mutant protein to misfold and form aggregates. By binding to the wild-type protein, these mutant proteins could trap the wild-type protein within these non-functional aggregates, preventing them from forming active dimers and thus leading to a loss-of-function.\n\n### Conclusion\n\nBoth A and D describe viable mechanisms for a dominant-negative effect in this context. However, the term \"dominant-negative\" most broadly describes the antagonism of the wild-type protein's function by the mutant protein. Both targeted degradation of the wild-type/mutant complex and sequestration of the wild-type protein into aggregates are specific ways this antagonism can occur.\n\nBetween the two, protein degradation is a very common cellular response to improperly formed protein complexes. A mutant subunit forming an abnormal dimer with a wild-type subunit creates precisely the kind of structure that cellular quality control systems like the proteasome are designed to eliminate. This leads to the functional loss of the wild-type allele's protein product.\n\n<<<A>>>"
  ],
  "user_prompt_list": [
    "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) protein degradation and loss-of-function of the wild-type allele\nB) change of protein conformation and gain-of-function phenotype\nC) loss of protein dimerization and wild-type phenotype\nD) protein aggregation and loss-of-function phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>"
  ],
  "system_message": ""
}